<SEC-DOCUMENT>0001213900-20-019648-index.html : 20200731 <SEC-HEADER>0001213900-20-019648.hdr.sgml : 20200731 <ACCEPTANCE-DATETIME>20200731163122 ACCESSION NUMBER: 0001213900-20-019648 CONFORMED SUBMISSION TYPE: S-3/A PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20200731 DATE AS OF CHANGE: 20200731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-239928 FILM NUMBER: 201066337 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>S-3/A <SEQUENCE>1 <FILENAME>ea124772-s3a1_soligenix.htm <DESCRIPTION>AMENDMENT NO.1 TO FORM S-3 <TEXT> Document 1 - file: ea124772-s3a1_soligenix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.11 <SEQUENCE>2 <FILENAME>ea124772ex4-11_soligenix.htm <DESCRIPTION>DESCRIPTION OF SECURITIES <TEXT> Document 2 - file: ea124772ex4-11_soligenix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ea124772ex23-1_soligenix.htm <DESCRIPTION>CONSENT OF EISNERAMPER LLP <TEXT> Document 3 - file: ea124772ex23-1_soligenix.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>img_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: img_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>img_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: img_002.jpg
</DOCUMENT> </SEC-DOCUMENT>